John J. Winge - Jan 5, 2023 Form 4 Insider Report for SeaSpine Holdings Corp (SPNE)

Role: Vice President, Sales
Signature: /s/Paul Benny, Attorney-in-Fact for John J. Winge
Stock symbol: SPNE
Transactions as of: Jan 5, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/9/2023, 06:18 PM
Previous filing: Jan 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SPNE	Common Stock	Disposed to Issuer		-91K	-100%		0	Jan 5, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SPNE	Restricted Stock Units	Disposed to Issuer		-14.4K	-100%		0	Jan 5, 2023	Common Stock	14.4K	$0.00	Direct	F2, F3, F4
transaction	SPNE	Restricted Stock Units	Disposed to Issuer		-30.2K	-100%		0	Jan 5, 2023	Common Stock	30.2K		Direct	F2, F5, F6
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-40K	-100%		0	Jan 5, 2023	Common Stock	40K	$15.68	Direct	F7, F8
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-59.6K	-100%		0	Jan 5, 2023	Common Stock	59.6K	$14.19	Direct	F9, F10
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-31.1K	-100%		0	Jan 5, 2023	Common Stock	31.1K	$18.24	Direct	F11, F12
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-48.7K	-100%		0	Jan 5, 2023	Common Stock	48.7K	$12.01	Direct	F13, F14
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-5.34K	-100%		0	Jan 5, 2023	Common Stock	5.34K	$9.93	Direct	F15, F16
transaction	SPNE	Employee Stock Option (Right to Buy)	Disposed to Issuer		-18.9K	-100%		0	Jan 5, 2023	Common Stock	18.9K	$15.00	Direct	F17, F18

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John J. Winge is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 37,862 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2	Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3	The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4	These restricted stock units were assumed by Orthofix in the merger and replaced by 6,008 Orthofix restricted stock units.
F5	The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6	These restricted stock units were assumed by Orthofix in the merger and replaced by 12,592 Orthofix restricted stock units.
F7	The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F8	This option was assumed by Orthofix in the merger and replaced with an option to purchase 16,652 shares of Orthofix at a price of $37.67 per share.
F9	The option vests in sixteen substantially equal quarterly installments beginning on March 31, 2016.
F10	This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,795 shares of Orthofix at a price of $34.09 per share.
F11	The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F12	This option was assumed by Orthofix in the merger and replaced with an option to purchase 12,954 shares of Orthofix at a price of $43.82 per share.
F13	The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14	This option was assumed by Orthofix in the merger and replaced with an option to purchase 20,264 shares of Orthofix at a price of $28.85 per share.
F15	The option fully vested and became exercisable on June 21, 2020.
F16	This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,223 shares of Orthofix at a price of $23.86 per share.
F17	The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F18	This option was assumed by Orthofix in the merger and replaced with an option to purchase 7,873 shares of Orthofix at a price of $36.04 per share.